Business Wire

CB Insights Unveils Industry's First AI Agent Workforce for M&A, Partnerships, Competitive Intelligence, Deal Sourcing, GTM, and More

26.6.2025 19:49:00 EEST | Business Wire | Press release

Share

CB Insights, the leading provider of predictive market intelligence, today announced the launch of its Team of Agents – the industry's first comprehensive AI agent workforce designed specifically to enable business leaders with always-on market intelligence for strategic decision-making. CB Insights’ growing team of agents starts with 11 specialized agents that work continuously to uncover insights, translate proprietary data into action, and accelerate smart decisions by providing the external intelligence layer that enterprises need to compete effectively across business development, investments, partnerships, GTM, and competitive intelligence.

While generic AI assistants struggle with business context and lack reliable external data, CB Insights' Team of Agents delivers validated intelligence and data science on over 10 million companies and 1,500 tech markets through purpose-built specialists that understand the nuanced requirements of strategic business functions.

Enterprise clients are already hiring CB Insights’ Team of Agents to streamline their workflows and accelerate decision-making across research, diligence, briefings, and more – saving months of work.

"The Scouting Report Agent is amazing – it's a huge time saver and lets us respond quickly with enough insight to get back to a client or be dangerous with," said Bethany Boutin, Business & Market Intelligence Lead: Commercial Solutions + Digital at Evernorth Health Services, a subsidiary of The Cigna Group.

"Most AI agents today are generalists trying to do everything – but when it comes to strategic decisions, you need specialists who understand your business context and have access to reliable external intelligence," said Manlio Carrelli, CEO of CB Insights. "Our Team of Agents represents the evolution from generic AI assistants to purpose-built intelligence operatives. They work around the clock on your behalf, each one an expert in their domain, all powered by our double-verified Business Graph and data science on the world's companies and markets – insights and data that are not available on ChatGPT, the Internet, or in any other agent."

Addressing the External Intelligence Gap

While most enterprise strategic decisions require external market intelligence about competitors, markets, and potential partners, existing AI tools often lack the specialized context and validated data necessary for high-stakes business decisions. CB Insights' growing Team of Agents solves this, starting with 11 specialized agents that deliver:

  • Acquisition Hunter: Identifies strategic acquisition targets and early-stage disruptors before competitors notice them
  • Business Relationship Analyst: Maps customer, vendor, and partner relationships to reveal strategic insights
  • ChatCBI: Serves as an AI-to-AI interface, allowing enterprises to integrate CB Insights intelligence directly into their existing AI workflows
  • Commercial Due Diligence Accelerator: Reduces due diligence timelines from weeks to hours with automated expert interviews and risk assessments
  • Competitive Sentinel: Monitors what competitors are buying, building, and investing in before it appears in financials
  • Deep Analyst: Generates comprehensive research reports and market analyses in hours instead of weeks
  • Earnings Analyst: Delivers CEO-ready competitive intelligence within hours of earnings calls
  • Partner and New Business Finder: Detects high-value partnership and sales opportunities using funding and competitive signals
  • Personal Briefing: Scours global news to surface personalized growth opportunities and competitive threats
  • Sales Account Planner: Accelerates rep ramp-up with deep account understanding and tailored pitch strategies
  • Scouting Report: Generates analyst-grade SWOT analyses on any private company on command

The agents listed are not exhaustive and CB Insights’ clients can create their own with Microsoft Copilot, MCP, and soon directly in ChatCBI.

Agents Powered by the World's Most Comprehensive Business Graph

Unlike AI agents that rely on public web data or limited datasets, CB Insights' Team of Agents operates on the proprietary Business Graph – a continuously validated dataset with patented data science covering management teams, funding rounds, partnerships, deals, earnings calls, hiring patterns, patents, and more across global business activity.

"The quality of AI output depends entirely on the quality of data input," said Carrelli. "Our agents don't just scrape the web – they work with double-verified intelligence based on proprietary information collected from companies and their customers directly, unique datasets like their commercial relationships, and proprietary data science that scores future potential. This means when our Competitive Sentinel tells you a rival is planning a major acquisition, or when our Acquisition Hunter identifies a strategic target, you can make decisions with confidence."

Designed for Enterprise Integration

The Team of Agents operates across multiple platforms where strategic work happens:

  • Native integration with CB Insights' Strategy Terminal for comprehensive market intelligence workflows
  • Microsoft 365 Copilot integration for seamless incorporation into existing productivity tools
  • Model Context Protocol (MCP) compatibility for any MCP-compatible AI agent to tap into CB Insights' datasets and tools – including ChatCBI – without a single line of code
  • API and custom solutions for embedding intelligence into enterprise applications and workflows
  • CB Insights’ forward-deployed strategists work with you to automate your research and strategy flows with custom agents

"We're not asking enterprises to change how they work – we're making their existing workflows dramatically more intelligent," said Carrelli. "Whether you're in Excel building a market model, in PowerPoint preparing for a board meeting, or doing deep work inside the CB Insights terminal, our agents provide the external intelligence you need exactly when and where you need it."

Availability and Pricing

CB Insights' Team of Agents is available immediately to enterprise customers through flexible deployment options. Individual agents can be deployed for specific use cases, or enterprises can access the full team for comprehensive market intelligence automation.

For more information about CB Insights' Team of Agents and to request a demonstration, visit www.cbinsights.com/team-of-agents.

About CB Insights

Headquartered in New York City, CB Insights is the leading provider of AI for market intelligence. The company aggregates, validates, and analyzes hard-to-find private and public company data. Its powerful AI tells users what it all means to them personally. The world's smartest companies rely on CB Insights to focus on the right markets, stay ahead of competitors, and identify the right targets for sales, partnership, or acquisition. Visit www.cbinsights.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250626444055/en/

Contacts

CB Insights
jason.saltzman@cbinsights.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye